↓ Skip to main content

Primary cardiac tumors on the verge of oblivion: a European experience over 15 years

Overview of attention for article published in Journal of Cardiothoracic Surgery, April 2015
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#24 of 280)
  • Good Attention Score compared to outputs of the same age (67th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

1 Wikipedia page


37 Dimensions

Readers on

40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Primary cardiac tumors on the verge of oblivion: a European experience over 15 years
Published in
Journal of Cardiothoracic Surgery, April 2015
DOI 10.1186/s13019-015-0255-4
Pubmed ID

Andreas Habertheuer, Günther Laufer, Dominik Wiedemann, Martin Andreas, Marek Ehrlich, Claus Rath, Alfred Kocher


Primary tumors of the heart represent an exceedingly rare entity in cardiac surgery and literature regarding management and outcome is rare. The aim of this study was to translate 15 years of experience in both multimodal diagnosis and surgical treatment of one of the largest collective of patients in literature into a detailed analysis of patient prognosis, mean survival and best treatment approach. All patients who underwent open-heart surgery at the Hospital of the Medical University of Vienna for primary cardiac tumor excision between 1999 and 2014 were analyzed retrospectively. Mean follow-up was 76.8 months. Descriptive statistical measurements were applied. 113 patients were identified, 71 (62.8%) female and 42 (37.2%) male patients with a mean age of 57.9 ± 16.8 years. 90.3% (n = 102) masses were benign, 9.7% (n = 11) were malignant. Complete resection was possible for 99% and for 18.2% of benign and malignant masses, respectively. 2.9% of benign tumors and 45.5% of malignant tumors relapsed. The 30-day mortality was 1.8% (n = 2). Mean survival was 187.2 ± 2.7 months and 26.2 ± 9.8 months for benign and malignant pathologies, respectively. Sarcoma patients who underwent adjuvant combination-chemotherapy or adjuvant mono-chemotherapy and radiation had a statistically significant survival advantage of 41,5 months. Primary cardiac tumors remain challenging in the clinical setting. A multimodality treatment approach especially for sarcoma patients prolongs mean survival and should be regarded as the standard of care.

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 20%
Student > Bachelor 5 13%
Student > Doctoral Student 5 13%
Student > Master 4 10%
Student > Ph. D. Student 4 10%
Other 9 23%
Unknown 5 13%
Readers by discipline Count As %
Medicine and Dentistry 28 70%
Agricultural and Biological Sciences 2 5%
Psychology 2 5%
Nursing and Health Professions 1 3%
Business, Management and Accounting 1 3%
Other 0 0%
Unknown 6 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2015.
All research outputs
of 5,387,274 outputs
Outputs from Journal of Cardiothoracic Surgery
of 280 outputs
Outputs of similar age
of 188,523 outputs
Outputs of similar age from Journal of Cardiothoracic Surgery
of 5 outputs
Altmetric has tracked 5,387,274 research outputs across all sources so far. This one has received more attention than most of these and is in the 63rd percentile.
So far Altmetric has tracked 280 research outputs from this source. They receive a mean Attention Score of 2.5. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 188,523 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them